Good afternoon :)
Switch to
Place Order

Nath Bio-Genes (I) Ltd

NATHBIOGEN
Consumer StaplesAgro Products
SmallcapWith a market cap of ₹502 cr, stock is ranked 1,205
High RiskStock is 3.01x as volatile as Nifty
263.251.05 (-0.40%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Consumer StaplesAgro Products
SmallcapWith a market cap of ₹502 cr, stock is ranked 1,205
High RiskStock is 3.01x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
9.03
PB RatioPB Ratio
0.82
Dividend YieldDiv. Yield
0.76%
Sector PESector PE
46.32
Sector PBSector PB
8.58
Sector Div YldSctr Div Yld
1.84%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Nath Bio-Genes (India) is engaged in hybrid seed business and production, processing and marketing of hybrid and genetically modified (GM) seeds

Investor PresentationView older 

Nov 1, 2021

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Financial TrendFinancial statements 

2018201920202021192.59233.20281.71309.2329.4338.4250.4955.65
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Loss of Share Certificates 
Announced OnNov 22, 2021

Nath Bio-Genes (India) Limited has informed the Exchange about Loss of Share Certificates | Download

Nath Bio-Genes (India) Limited has informed the Exchange about Loss of Share Certificates | Download

Analysts/Institutional Investor Meet/Con. Call Updates 
Announced OnNov 8, 2021

Nath Bio-Genes (India) Limited has informed the Exchange about Transcript of Concall | Download

Nath Bio-Genes (India) Limited has informed the Exchange about Transcript of Concall | Download

Cash Dividend 
Ex. DateAug 18, 2021

Final • Div/Share: ₹ 2

See all events